Ottawa, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Precedence Research, Recently Published Report on “Single Cell Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030”.
Key Takeaways:
- By product, the consumables segments have held market share of 53% in 2022.
- By application, the cancer segments have captured revenue share of 33% in 2022.
- By end user, the research and academic laboratories segment has generated market share of 73% in 2022.
- The North America region has accounted for 37% of the market share in 2022.
Get the sample copy of report@ https://www.precedenceresearch.com/sample/2400
Regional Snapshots
North American region has dominated the single cell analysis market in the past due to the advancement in technologies and constant research and development in this region. This region will have a significant share even in the coming years in terms of revenue. Maximum revenue will be generated in the North American region. As many market players are present in the North American region and this region will have an upper hand as compared to the other regions across the world.
The need for this technology has grown in the Asia Pacific region. Increased awareness will play a significant role in the growth of this market during the forecast period. As the health care services have improved in this region and the amount of money spent on its development has also grown in the recent years the market is also expected to develop. The use of novel technologies and tools will also drive the market growth. As many trained personnel are available in the Asia Pacific region this shall contribute to the growth of the market. Geriatric population has also increased in the Asia Pacific region and this shall also prove to be an instrumental factor in the growth of the market.
Report highlights
- On the basis of the product, the consumable segment will show a significant growth during the forecast period from the year 2022 till the year 2030 and it will grow with the highest compound annual growth rate. As the sales of the reagents and buffers have also increased in the recent years the consumable segment is expected to grow. Many consumables are in great demand due to the constant scientific activities in the market.
- On the basis of application, the cancer segment will have a dominant position in the coming years. According to the research conducted a lot of cases of death have occurred due to cancer and this is expected to grow in the coming years.
- The research activities in this field have also increased in order to evaluate proteomics and genomics of single cell. The need for therapies in the stem cell has also increased due to which the market is expected to grow and show a significant development. The use of the single cell analysis technique in the research laboratories and the academic laboratories will generate maximum revenue in the coming years. Increase in the number of scientific projects across the world will drive the market growth. The amount of money invested in the genomics have also increased due to which the market will show a significant growth.
- Library preparation and single cell isolation segment is also expected to have the largest market share on the basis of the workflow. Many new products are offered by the industrial players which will increase the revenue of the market.
- Downstream analysis segment will also show a significant growth as many new technologies are introduced in the market. Automation and the use of artificial intelligence in data analysis will provide good opportunities for the growth of this segment. Flexibility and better success rate or acquired due to the use of artificial intelligence and automation.
Recent Developments
- Boehringer Ingelheim entered into a partnership with Lifebit in the year 2022 this partnership aims at building the infrastructure for data analytics which is expected to be the first of its kind platform for the genomics.
Ask here for more customization study@ https://www.precedenceresearch.com/customization/2400
Scope of the Report
| Report Attributes | Details | |
| Revenue Forecast by 2030 | USD 18.59 Billion | |
| CAGR | 18.22% from 2022 to 2030 | |
| North America Market Share in 2022 | 38% | |
| Asia Pacific Market Share in 2022 | 27.6% | |
| Base Year | 2022 | |
| Forecast Year | 2023 to 2030 | |
| Key Players | Thermo Fisher Scientific, Novogene corporation, Illumina Inc, BGI, Fluidigm corporation and others. | |
Market dynamics
Drivers
As the cases of cancer have increased and the that's that occurred due to this disease have also increased in various nations across the world the demand for a single cell analysis is expected to grow in the coming years. By the year 2040 it is estimated that there will be 30 million cases of cancer. The growing demand for research and diagnosis for the treatment of this disease will drive the market growth for single cell analysis in the coming years beaded this technology plays a very significant role in the research conducted in the field. would you take the disease and two understand the effect of the treatment and the efficiency of the treatment on the human the need of this technique is expected to grow in the coming years. It also helps in monitoring the amount of spread of the tumors associated with breast cancer and it also helps in monitoring the extent of the spread of the tumors in different malignancies.
Restraints
When it comes to the research conducted in the field expensive products are used and these products available in the market are of the higher quality. In order to comply with the regulatory guidelines which are set by the authorities of various nations the research becomes expensive. In order to maintain a good quality the use of expensive products make the research expensive. Acquiring expensive instruments is difficult for the research laboratories and the academic laboratories. These laboratories have budget constraints due to which the market growth will be hampered in the coming years. Maintenance costs of these instruments is also high due to which these instruments are not purchased by many organizations. All of these factors will hamper the growth of the market and they will also reduce the use of microfluidic devices and flow cytometer's for conducting research or even in the clinical applications.
Opportunities
One of the powerful tool existing in the market is the single cell sequencing technique. It helps in detecting and monitoring onset of the disease and the progression in the disease. It also helps in monitoring the response of the patient to a particular treatment or the line of treatment adopted. It also helps in providing details about the genetic mutations. Market players are constantly engaged on coming up with reagents and instruments which will be extremely compatible with the single cell sequencers. Many new products will be launched and developed in the coming years as this technique is expected to have a greater demand in the coming years.
Challenges
There are many technical limitations that will hamper the growth of the market in the long run. Expensive products used in single cell analysis will also challenge the growth of the market in the long run.
- Browse more healthcare industry research reports@ https://www.precedenceresearch.com/industry/healthcare
Market Segmentation
By Product
- Consumables
- Instruments
By Application
- Cancer
- Neurology
- Stem cell
- Immunology next line in vitro fertilization
- Noninvasive prenatal diagnosis
By Workflow
- Downstream analysis
- Single cell isolation and library preparation
- Data analysis
By End User
- Research and Academic Laboratories
- Biotechnology & Pharmaceutical Companies
- Hospitals & Diagnostic Laboratories
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Immediate Delivery Available | Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/2400
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
For Latest Update Follow Us:
https://www.linkedin.com/company/precedence-research/
https://www.facebook.com/precedenceresearch/
https://twitter.com/Precedence_R
